Skip to main content
SpringerLink
Log in

Dopamine transporter SPECT imaging in Parkinson’s disease and atypical Parkinsonism: a study of 137 patients

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Introduction

Differential diagnosis between Parkinson’s disease (PD) and multiple system atrophy–parkinsonian type (MSA-P), corticobasal degeneration (CBD), and progressive supranuclear palsy (PSP), collectively termed atypical Parkinsonism (AP), is challenging. Dopamine transporter density imaging with Ioflupane I123 (DaTscan) is a marker of presynaptic nigrostriatal dysfunction. The primary aim of this study was to investigate the utility of DaTscan in the differential diagnosis of MSA-P, CBD, and PSP.

Methods

Patients examined at Eginition Hospital (2011–2021), with available DaTscan data and a diagnosis of probable AP, clinically established PD, as well as a neurological control (NC) group were included. Mean binding specific index (BSI), BSI of the most affected side, asymmetry index, laterality, and caudate/putamen ratio were recorded. Analyses were performed by Kruskal-Wallis and ANCOVA.

Results

137 patients were included (CBD: \(n =28\); MSA-P: \(n =15\); PSP: \(n =42\); PD: \(n =17\); NC: \(n =35\)). There were significant differences when comparing CBS, PSP, and NC vs. all other groups combined. Pairwise between-group comparisons revealed significant differences between PSP and CBD (mean striatum BSI>1.95; sensitivity 74.1%; specificity 85.0%), CBD and MSA-P (mean striatum BSI>2.04; sensitivity 70.4%; specificity 86.7%), and CBD and PD (mean striatum BSI>2.11; sensitivity 66.7%; specificity 100.0%). There were no differences between PSP, MSA-P, and PD. PSP, MSA-P, and PD differed from NC subjects, with 100% specificity and high sensitivity. Differentiation of NC from CBD was suboptimal.

Discussion

CBD patients exhibit relatively mild DaTscan abnormalities. DaTscan may assist in the differentiation of CBD from PSP. DaTscan does not differentiate among PD, MSA-P, and PSP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Data availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.

References

  1. (2000) A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. Parkinson Study Group. Neurology 55:1540-1547

  2. Antonini A, Benti R, De Notaris R, Tesei S, Zecchinelli A, Sacilotto G, Meucci N, Canesi M, Mariani C, Pezzoli G, Gerundini P (2003) 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy. Neurol Sci 24:149–150

    Article  CAS  PubMed  Google Scholar 

  3. Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, Boxer AL, Dickson DW, Grossman M, Hallett M, Josephs KA, Kertesz A, Lee SE, Miller BL, Reich SG, Riley DE, Tolosa E, Troster AI, Vidailhet M, Weiner WJ (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology 80:496–503

    Article  PubMed  PubMed Central  Google Scholar 

  4. Benamer HTS, Patterson J, Grosset DG, Booij J, de Bruin K, van Royen E, Speelman JD, Horstink M, Sips H, Dierckx RA, Versijpt J, Decoo D, Van Der Linden C, Hadley DM, Doder M, Lees AJ, Costa DC, Gacinovic S, Oertel WH, Pogarell O, Hoeffken H, Joseph K, Tatsch K, Schwarz J, Ries V (2000) Accurate differentiation of parkinsonism and essential tremor using visual assessment of [(123) I]-FP-CIT SPECT imaging: the [(123) I]-FP-CIT study group. Mov Disord 15:503–510

    Article  CAS  PubMed  Google Scholar 

  5. Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED, Raethjen J, Stamelou M, Testa CM, Deuschl G, Tremor Task Force of the International P, Movement Disorder S (2018) Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord 33:75–87

    Article  Google Scholar 

  6. Booij J, Speelman JD, Horstink MW, Wolters EC (2001) The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med 28:266–272

    Article  CAS  PubMed  Google Scholar 

  7. Ceravolo R, Rossi C, Cilia R, Tognoni G, Antonini A, Volterrani D, Bonuccelli U (2013) Evidence of delayed nigrostriatal dysfunction in corticobasal syndrome: a SPECT follow-up study. Parkinsonism Relat Disord 19:557–559

    Article  PubMed  Google Scholar 

  8. Cilia R, Rossi C, Frosini D, Volterrani D, Siri C, Pagni C, Benti R, Pezzoli G, Bonuccelli U, Antonini A, Ceravolo R (2011) Dopamine transporter SPECT imaging in corticobasal syndrome. PLoS One 6:e18301

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Constantinides VC, Souvatzoglou M, Paraskevas GP, Chalioti M, Boufidou F, Stefanis L, Kapaki E (2022) Dopamine transporter SPECT imaging in corticobasal syndrome: a peak into the underlying pathology? Acta Neurol Scand 145:762–769

    Article  CAS  PubMed  Google Scholar 

  10. Darcourt J, Booij J, Tatsch K, Varrone A, Vander Borght T, Kapucu OL, Nagren K, Nobili F, Walker Z, Van Laere K (2010) EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging 37:443–450

    Article  CAS  PubMed  Google Scholar 

  11. Filippi L, Manni C, Pierantozzi M, Brusa L, Danieli R, Stanzione P, Schillaci O (2006) 123I-FP-CIT in progressive supranuclear palsy and in Parkinson’s disease: a SPECT semiquantitative study. Nucl Med Commun 27:381–386

    Article  PubMed  Google Scholar 

  12. Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Durr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670–676

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Grachev I, Sherwin P, Lane D, Moreno E, Freid J, Bajaj N, Hauser RA, Seibyl J, Grosset DG, Marek K (2013) DaTSCAN™ (ioflupane I 123 injection), a radiopharmaceutical indicated for visualization of the striatal dopamine transporter using SPECT: Safety profile review. J Neurol Sci 333:e84

    Article  Google Scholar 

  14. Hammesfahr S, Antke C, Mamlins E, Beu M, Wojtecki L, Ferrea S, Dinkelbach L, Moldovan AS, Schnitzler A, Muller HW, Sudmeyer M (2016) FP-CIT- and IBZM-SPECT in corticobasal syndrome: results from a clinical follow-up study. Neurodegener Dis 16:342–347

    Article  CAS  PubMed  Google Scholar 

  15. Hoglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Muller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I, Movement Disorder Society-endorsed PSPSG (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853–864

    Article  Google Scholar 

  16. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Im JH, Chung SJ, Kim JS, Lee MC (2006) Differential patterns of dopamine transporter loss in the basal ganglia of progressive supranuclear palsy and Parkinson’s disease: analysis with [(123)I]IPT single photon emission computed tomography. J Neurol Sci 244:103–109

    Article  CAS  PubMed  Google Scholar 

  18. Iwabuchi Y, Kameyama M, Matsusaka Y, Narimatsu H, Hashimoto M, Seki M, Ito D, Tabuchi H, Yamada Y, Jinzaki M (2021) A diagnostic strategy for Parkinsonian syndromes using quantitative indices of DAT SPECT and MIBG scintigraphy: an investigation using the classification and regression tree analysis. Eur J Nucl Med Mol Imaging 48:1833–1841

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Knudsen GM, Karlsborg M, Thomsen G, Krabbe K, Regeur L, Nygaard T, Videbaek C, Werdelin L (2004) Imaging of dopamine transporters and D2 receptors in patients with Parkinson’s disease and multiple system atrophy. Eur J Nucl Med Mol Imaging 31:1631–1638

    Article  CAS  PubMed  Google Scholar 

  20. Nocker M, Seppi K, Donnemiller E, Virgolini I, Wenning GK, Poewe W, Scherfler C (2012) Progression of dopamine transporter decline in patients with the Parkinson variant of multiple system atrophy: a voxel-based analysis of [123I]beta-CIT SPECT. Eur J Nucl Med Mol Imaging 39:1012–1020

    Article  CAS  PubMed  Google Scholar 

  21. Perju-Dumbrava LD, Kovacs GG, Pirker S, Jellinger K, Hoffmann M, Asenbaum S, Pirker W (2012) Dopamine transporter imaging in autopsy-confirmed Parkinson’s disease and multiple system atrophy. Mov Disord 27:65–71

    Article  PubMed  Google Scholar 

  22. Pirker S, Perju-Dumbrava L, Kovacs GG, Traub-Weidinger T, Pirker W (2015) Progressive dopamine transporter binding loss in autopsy-confirmed corticobasal degeneration. J Parkinsons Dis 5:907–912

    Article  CAS  PubMed  Google Scholar 

  23. Pirker W, Asenbaum S, Bencsits G, Prayer D, Gerschlager W, Deecke L, Brucke T (2000) [123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. Mov Disord 15:1158–1167

    Article  CAS  PubMed  Google Scholar 

  24. Plotkin M, Amthauer H, Klaffke S, Kuhn A, Ludemann L, Arnold G, Wernecke KD, Kupsch A, Felix R, Venz S (2005) Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients. J Neural Transm (Vienna) 112:677–692

    Article  CAS  PubMed  Google Scholar 

  25. Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30:1591–1601

    Article  PubMed  Google Scholar 

  26. Scherfler C, Seppi K, Donnemiller E, Goebel G, Brenneis C, Virgolini I, Wenning GK, Poewe W (2005) Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson’s disease. Brain 128:1605–1612

    Article  PubMed  Google Scholar 

  27. Seppi K, Scherfler C, Donnemiller E, Virgolini I, Schocke MF, Goebel G, Mair KJ, Boesch S, Brenneis C, Wenning GK, Poewe W (2006) Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis. Arch Neurol 63:1154–1160

    Article  PubMed  Google Scholar 

  28. Shigekiyo T, Arawaka S (2020) Laterality of specific binding ratios on DAT-SPECT for differential diagnosis of degenerative parkinsonian syndromes. Sci Rep 10:15761

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Stoffers D, Booij J, Bosscher L, Winogrodzka A, Wolters EC, Berendse HW (2005) Early-stage [123I]beta-CIT SPECT and long-term clinical follow-up in patients with an initial diagnosis of Parkinson’s disease. Eur J Nucl Med Mol Imaging 32:689–695

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. First Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, Eginition Hospital, 72-74 Vas. Sophias Ave., 11528, Athens, Greece

    Vasilios C. Constantinides, Leonidas Stefanis & Elisabeth Kapaki

  2. Nuclear Medicine Division, First Radiology Department, National and Kapodistrian University of Athens, Aretaieion Hospital, Athens, Greece

    Michail Souvatzoglou & Maria Chalioti

  3. Second Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, Attikon Hospital, Athens, Greece

    George P. Paraskevas

Authors
  1. Vasilios C. Constantinides
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michail Souvatzoglou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. George P. Paraskevas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria Chalioti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Leonidas Stefanis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Elisabeth Kapaki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vasilios C. Constantinides.

Ethics declarations

Ethical approval

The study was performed according to the ethical guidelines of the 1964 Declaration of Helsinki and was approved by the Scientific and Ethical Committee of Eginition Hospital.

Informed consent

Written informed consent was obtained by all patients. The next of kin caregiver gave written informed consent in cases of compromised mental capacity.

Conflict of interest

None.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (JPG 514 KB)

Supplementary file2 (JPG 2114 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Constantinides, V.C., Souvatzoglou, M., Paraskevas, G.P. et al. Dopamine transporter SPECT imaging in Parkinson’s disease and atypical Parkinsonism: a study of 137 patients. Neurol Sci 44, 1613–1623 (2023). https://doi.org/10.1007/s10072-023-06628-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-023-06628-9

Keywords

Search

Navigation